An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical Practice
Therapeutic Strategies Including Avastin as 1st Line Therapy in Elderly Patients Suffering From Advanced (IIIB/IV Stage) Non-squamous Non-small Cell Lung Cancer, in Routine Clinical Practice.
Sponsor: Hoffmann-La Roche
A observational or N/A phase clinical study on Non-Squamous Non-Small Cell Lung Cancer, this trial is completed. The trial is conducted by Hoffmann-La Roche and has accumulated 8 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Status: Active Not Recruiting → Completed · Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Oct 2017 [monthly]
Active Not Recruiting NA
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hoffmann-La Roche
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Agen, France , Aix-en-Provence, France , Amiens, France , Angers, France , Bayonne, France , Besançon, France , Beuvry, France , Bobigny, France , Bordeaux, France , Bourg-en-Bresse, France and 66 more locations